Evidence map›Paper›PMID 22654114›Full record

ArticleThe Journal of biological chemistry2012

Proteomic identification of glycosylphosphatidylinositol anchor-dependent membrane proteins elevated in breast carcinoma.

Peng Zhao, Alison V Nairn, Shanterian Hester, Kelley W Moremen, Ruth M O'Regan, Gabriella Oprea, Lance Wells, Michael Pierce, Karen L Abbott

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Anti-tumor Effects of Recombinant Clostridium α-Toxin on Breast Cancer: AnInternational journal of molecular and cellular medicine · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. PIGG variant pathogenicity assessment reveals characteristic features within 19 families.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Synthesis and evaluation of NOrganic & biomolecular chemistry · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Peng ZhaoDepartment of Chemistry, University of Georgia, Athens, Georgia 30605, USA.
Alison V Nairn
Shanterian Hester
Kelley W Moremen
Ruth M O'Regan
Gabriella Oprea
Lance Wells
Michael Pierce
Karen L Abbott
University of Georgia · USEmory University · US

Funding

TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)P41GM103490 · NIGMS · UNIVERSITY OF GEORGIA · PI PIERCE, J. MICHAEL · 2012 to 2018
$13.7M
ZINC DEFICIENCY &PROTEIN EXPRESSION IN RAT OLFACTORY BULBSP41RR018502 · NCRR · UNIVERSITY OF GEORGIA (UGA) · PI PIERCE, J. MICHAEL · 2003 to 2011
$13.1M
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer MarkersU01CA128454 · NCI · UNIVERSITY OF GEORGIA · PI PIERCE, J. MICHAEL · 2007 to 2017
$5.7M
NCI NIH HHS BC075534NCI NIH HHS U01 CA128454NCI NIH HHS UO1CA128454NCRR NIH HHS P41 RR018502NCRR NIH HHS P41RR018502NIGMS NIH HHS P41 GM103490
6 · The paper itself

Abstract

The glycosylphosphatidylinositol (GPI) anchor is a lipid and glycan modification added to the C terminus of certain proteins in the endoplasmic reticulum by the activity of a multiple subunit enzyme complex known as the GPI transamidase (GPIT). Several subunits of GPIT have increased expression levels in breast carcinoma. In an effort to identify GPI-anchored proteins and understand the possible role of these proteins in breast cancer progression, we employed a combination of strategies. First, alpha toxin from Clostridium septicum was used to capture GPI-anchored proteins from human breast cancer tissues, cells, and serum for proteomic analysis. We also expressed short interfering RNAs targeting the expression of the GPAA1 and PIGT subunits of GPIT in breast cancer cell lines to identify proteins in which membrane localization is dependent on GPI anchor addition. Comparative membrane proteomics using nano-ESI-RPLC-MS/MS led to the discovery of several new potential diagnostic and therapeutic targets for breast cancer. Furthermore, we provide evidence that increased levels of GPI anchor addition in malignant breast epithelial cells promotes the dedifferentiation of malignant breast epithelial cells in part by increasing the levels of cell surface markers associated with mesenchymal stem cells.

Indexed as

Bacterial ToxinsBiomarkers, TumorBreast NeoplasmsCarcinomaCell LineEpithelial CellsFemaleGlycosylphosphatidylinositolsGPI-Linked ProteinsHumansMesenchymal Stem CellsNeoplasm ProteinsProteomicsBacterial ToxinsBiomarkers, TumorGlycosylphosphatidylinositolsGPI-Linked Proteinshemolytic toxin, Clostridium septicumNeoplasm Proteins

Identifiers

PMID22654114
PMCPMC3408190
OpenAlexW2120583301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.